Source: Nature Communications. Unidade: FCF
Subjects: ANÁLISE MORFOLÓGICA, CÉLULAS, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Beatriz et al. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. Nature Communications, v. 16, p. 1-15 art. 5533, 2025Tradução . . Disponível em: https://dx.doi.org/10.1038/s41467-025-60224-3. Acesso em: 04 dez. 2025.APA
Chaves, B., Silva, J. C. S. e, Nakaya, H. T. I., Juglard, N. S., Bucciarelli, F., Prunier, G., et al. (2025). In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. Nature Communications, 16, 1-15 art. 5533. doi:10.1038/s41467-025-60224-3NLM
Chaves B, Silva JCS e, Nakaya HTI, Juglard NS, Bucciarelli F, Prunier G, Almeida MV, Lacouture C, Kari S, Astier AL, Medeiros MA, Silva JHM, Liblau R, Almeida VC de, Dupré L. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis [Internet]. Nature Communications. 2025 ; 16 1-15 art. 5533.[citado 2025 dez. 04 ] Available from: https://dx.doi.org/10.1038/s41467-025-60224-3Vancouver
Chaves B, Silva JCS e, Nakaya HTI, Juglard NS, Bucciarelli F, Prunier G, Almeida MV, Lacouture C, Kari S, Astier AL, Medeiros MA, Silva JHM, Liblau R, Almeida VC de, Dupré L. In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis [Internet]. Nature Communications. 2025 ; 16 1-15 art. 5533.[citado 2025 dez. 04 ] Available from: https://dx.doi.org/10.1038/s41467-025-60224-3
